Rokit Healthcare Appoints Lee Na-dan as CTO to Accelerate U.S. Regenerative Platform Efforts

Rokit Healthcare announced the appointment of Lee Na-dan as chief technology officer. Lee Na-dan brings experience in biotechnology and platform development. The hire is intended to fast‑track the company’s U.S. regenerative medicine push. Rokit aims to expand its platform for tissue regeneration and related therapies. The new CTO will oversee technology strategy and product roadmaps. The move reflects Rokit’s ambition to capture market share in the United States. Company officials expect accelerated progress on upcoming clinical programs. The announcement was covered by CHOSUNBIZ.